- Home
- CADL vs MMT Comparison
CADL vs MMT Comparison
Compare CADL & MMT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CADL
- MMT
- Stock Information
- Founded
- CADL 1999
- MMT 1987
- Country
- CADL United States
- MMT United States
- Employees
- CADL N/A
- MMT N/A
- Industry
- CADL Biotechnology: Pharmaceutical Preparations
- MMT Trusts Except Educational Religious and Charitable
- Sector
- CADL Health Care
- MMT Finance
- Exchange
- CADL Nasdaq
- MMT Nasdaq
- Market Cap
- CADL 313.5M
- MMT 255.0M
- IPO Year
- CADL 2021
- MMT N/A
- Fundamental
- Price
- CADL $4.79
- MMT $4.85
- Analyst Decision
- CADL Strong Buy
- MMT
- Analyst Count
- CADL 5
- MMT 0
- Target Price
- CADL $19.80
- MMT N/A
- AVG Volume (30 Days)
- CADL 724.9K
- MMT 86.5K
- Earning Date
- CADL 08-14-2025
- MMT 01-01-0001
- Dividend Yield
- CADL N/A
- MMT 8.58%
- EPS Growth
- CADL N/A
- MMT N/A
- EPS
- CADL N/A
- MMT 0.30
- Revenue
- CADL N/A
- MMT N/A
- Revenue This Year
- CADL N/A
- MMT N/A
- Revenue Next Year
- CADL N/A
- MMT N/A
- P/E Ratio
- CADL N/A
- MMT $15.33
- Revenue Growth
- CADL N/A
- MMT N/A
- 52 Week Low
- CADL $3.79
- MMT $4.04
- 52 Week High
- CADL $14.60
- MMT $4.70
- Technical
- Relative Strength Index (RSI)
- CADL 32.97
- MMT 71.63
- Support Level
- CADL $4.81
- MMT $4.71
- Resistance Level
- CADL $5.01
- MMT $4.84
- Average True Range (ATR)
- CADL 0.30
- MMT 0.04
- MACD
- CADL -0.08
- MMT 0.01
- Stochastic Oscillator
- CADL 3.18
- MMT 94.44
About CADL Candel Therapeutics Inc.
Candel Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing viral immunotherapies to help patients fight cancer. The company has established two clinical-stage viral immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) constructs, respectively.
About MMT MFS Multimarket Income Trust
MFS Multimarket Income Trust is a diversified closed-end management investment company. Its investment objective is to seek high current income, but may also consider capital appreciation. The fund invests a majority of its net assets in fixed-income securities, corporate bonds of the U.S and foreign issuers, U.S Government securities, foreign government securities, mortgage-backed and other asset-backed securities of U.S and foreign issuers, and debt instruments of issuers located in emerging market countries. The portfolio of investments comprises of different sector investments such as aerospace, airlines, automotive, chemicals, electronics, and others.